Sean McCutcheon
Stock Analyst at Raymond James
(3.26)
# 2,826
Out of 5,182 analysts
12
Total ratings
41.67%
Success rate
28.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $8.79 | +173.04% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $131.67 | -42.28% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $10.64 | +12.78% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $15.23 | +326.79% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $1.79 | +402.79% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.92 | +276.71% | 1 | Jul 1, 2025 | |
| ENGN enGene Therapeutics | Initiates: Outperform | $23 | $7.20 | +219.44% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $13.10 | +205.34% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $61.60 | +13.64% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $23.65 | +263.64% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $8.79
Upside: +173.04%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $131.67
Upside: -42.28%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $10.64
Upside: +12.78%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $15.23
Upside: +326.79%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $1.79
Upside: +402.79%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.92
Upside: +276.71%
enGene Therapeutics
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $7.20
Upside: +219.44%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $13.10
Upside: +205.34%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $61.60
Upside: +13.64%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $23.65
Upside: +263.64%